vor 5 Jahren

ROUNDUP: Bayer stellt Arbeit an Hustenmittel ein - Kurseinbruch bei Evotec

HAMBURG (dpa-AFX) - Der Wirkstoffforscher Evotec (EVOTEC SE) muss bei der Kooperation mit Bayer einen Rückschlag hinnehmen. Bayer stellt die Entwicklung des P2X3-Antagonisten Eliapixant ein, wie das MDAX-Unternehmen am Freitag in Hamburg mitteilte.

Quelle: Börse Online RSS Feed

There are people out there who still trust government currency.vor 10 Stunden
When You Control Your Bitcoin, You’re Responsible for It Too.vor 10 Stunden
Brazil's largest crypto exchange, Mercado Bitcoin, suspends deposits and withdrawals after reportedly being hacked for over $40 million.vor 11 Stunden
Found something weird on my uncle’s old mining laptop from 2010. Has anyone ever heard of “Old Diff” the tortoise? [LONG]vor 11 Stunden
Bitcoin Suisse CEO: Switzerland has lost interest in cryptocurrenciesvor 12 Stunden
The Bitcoin Cash Podcast #193: BLAZE Registration & Mina Upgrade feat. Elliot Pricevor 13 Stunden
Who controls the private keys of governments' Bitcoin wallets?vor 13 Stunden
The $6.3B Question: Is Binance Running on Fractional Reserves Like FTX, and Will It Take Mass Withdrawals to Expose It?vor 16 Stunden
Infernet Protocol — We're doing to AI what Bitcoin did to moneyvor 17 Stunden
somehow, it's never enough.vor 18 Stunden